The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A clinically applicable molecular-based classification for endometrial cancers
Open accessAbstract
BACKGROUND: Classification of endometrial carcinomas (ECs) by morphologic features is inconsistent, and yields limited prognostic and predictive information. A new system for classification based on the molecular categories identified in The Cancer Genome Atlas is proposed. METHODS: Genomic data from the Cancer Genome Atlas (TCGA) support classification of endometrial carcinomas into four prognostically significant subgroups; we used the TCGA data set to develop surrogate assays that could replicate the TCGA classification, but without the need for the labor-intensive and cost-prohibitive genomic methodology. Combinations of the most relevant assays were carried forward and tested on a new independent cohort of 152 endometrial carcinoma cases, and molecular vs clinical risk group stratification was compared. RESULTS: Replication of TCGA survival curves was achieved with statistical significance using multiple different molecular classification models (16 total tested). Internal validation supported carrying forward a classifier based on the following components: mismatch repair protein immunohistochemistry, POLE mutational analysis and p53 immunohistochemistry as a surrogate for 'copy-number' status. The proposed molecular classifier was associated with clinical outcomes, as was stage, grade, lymph-vascular space invasion, nodal involvement and adjuvant treatment. In multivariable analysis both molecular classification and clinical risk groups were associated with outcomes, but differed greatly in composition of cases within each category, with half of POLE and mismatch repair loss subgroups residing within the clinically defined 'high-risk' group. Combining the molecular classifier with clinicopathologic features or risk groups provided the highest C-index for discrimination of outcome survival curves. CONCLUSIONS: Molecular classification of ECs can be achieved using clinically applicable methods on formalin-fixed paraffin-embedded samples, and provides independent prognostic information beyond established risk factors. This pragmatic molecular classification tool has potential to be used routinely in guiding treatment for individuals with endometrial carcinoma and in stratifying cases in future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Internal validation of predictive models
Steyerberg, E. W., Harrell, F. E., Borsboom, G. J. J. M., Eijkemans, M. J. C., Vergouwe, Y., & Habbema, J. D. F. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00341-9 · Cited by 2,746
A note on quantifying follow-up in studies of failure time
Schemper, M., & Smith, T. L. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(96)00075-x · Cited by 2,575
Creutzberg, C. L., van Putten, W. L., Koper, P. C., Lybeert, M. L., Jobsen, J. J., Wárlám-Rodenhuis, C. C., De Winter, K. A., Lutgens, L. C., van den Bergh, A. C., van de Steen-Banasik, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02139-5 · Cited by 1,773
Keys, H. M., Roberts, J. A., Brunetto, V. L., Zaino, R. J., Spirtos, N. M., Bloss, J. D., Pearlman, A., Maiman, M. A., & Bell, J. G. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.048 · Cited by 1,671
Improvements on Cross-Validation: The 632+ Bootstrap Method
Efron, B., & Tibshirani, R. (1997) · Journal of the American Statistical Association · doi:10.1080/01621459.1997.10474007 · Cited by 1,636
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I.-M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,073
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
Self-citationMariani, A., Dowdy, S. C., Cliby, W. A., Gostout, B. S., Jones, M. B., Wilson, T. O., & Podratz, K. C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.023 · Cited by 810
Classification of endometrial carcinoma: more than two types
Murali, R., Soslow, R. A., & Weigelt, B. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70591-6 · Cited by 647
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt353 · Cited by 600
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., & Sessa, C. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr374 · Cited by 574
Sinicrope, F. A., Foster, N. R., Thibodeau, S. N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M. J., Gallinger, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr153 · Cited by 543
Stelloo, E., Bosse, T., Nout, R. A., MacKay, H. J., Church, D. N., Nijman, H. W., Leary, A., Edmondson, R. J., Powell, M. E., Crosbie, E. J., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.43 · Cited by 486
NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, Le Gallo, M., O'Hara, A. J., Rudd, M. L., Urick, M. E., Hansen, N. F., O'Neil, N. J., Price, J. C., Zhang, S., England, B. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2455 · Cited by 419
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
Gilks, C. B., Oliva, E., & Soslow, R. A. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827f576a · Cited by 401
Self-citationLu, K. H., Dinh, M., Kohlmann, W., Watson, P., Green, J., Syngal, S., Bandipalliam, P., Chen, L.-M., Allen, B., Conrad, P., et al. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000154885.44002.ae · Cited by 379
Evolution of Translational Omics: Lessons Learned and the Path Forward
Micheel, C., Nass, S. J., & Omenn, G. S. (2013) · Cited by 365
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
Church, D. N., Stelloo, E., Nout, R. A., Valtcheva, N., Depreeuw, J., ter Haar, N., Noske, A., Amant, F., Tomlinson, I. P. M., Wild, P. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju402 · Cited by 332
Use of mutation profiles to refine the classification of endometrial carcinomas
McConechy, M. K., Ding, J., Cheang, M. C., Wiegand, K. C., Senz, J., Tone, A. A., Yang, W., Prentice, L. M., Tse, K., Zeng, T., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4056 · Cited by 301
Self-citationSalvesen, H. B., Carter, S. L., Mannelqvist, M., Dutt, A., Getz, G., Stefansson, I. M., Raeder, M. B., Sos, M. L., Engelsen, I. B., Trovik, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806514106 · Cited by 290
USA endometrial cancer projections to 2030: should we be concerned?
Sheikh, M. A., Althouse, A. D., Freese, K. E., Soisson, S., Edwards, R. P., Welburn, S., Sukumvanich, P., Comerci, J., Kelley, J., LaPorte, R. E., et al. (2014) · Future Oncology · doi:10.2217/fon.14.192 · Cited by 236
Hussein, Y. R., Weigelt, B., Levine, D. A., Schoolmeester, J. K., Dao, L. N., Balzer, B. L., Liles, G., Karlan, B., Köbel, M., Lee, C.-H., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.143 · Cited by 220
McConechy, M. K., Talhouk, A., Li-Chang, H. H., Leung, S., Huntsman, D. G., Gilks, C. B., & McAlpine, J. N. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.541 · Cited by 218
Self-citationReproducibility of histological cell type in high-grade endometrial carcinoma
Han, G., Sidhu, D., Duggan, M. A., Arseneau, J., Cesari, M., Clement, P. B., Ewanowich, C. A., Kalloger, S. E., & Köbel, M. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.102 · Cited by 203
Pipelle endometrial sampling in patients with known endometrial carcinoma.
Stovall, T., Photopulos, G. J., Poston, W., Ling, F., & Sandles, L. (1991) · PubMed · Cited by 195
Meng, B., Hoang, L. N., McIntyre, J. B., Duggan, M. A., Nelson, G. S., Lee, C.-H., & Köbel, M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.05.006 · Cited by 185
Billingsley, C. C., Cohn, D. E., Mutch, D. G., Stephens, J. A., Suarez, A. A., & Goodfellow, P. J. (2015) · Cancer · doi:10.1002/cncr.29046 · Cited by 176
Diagnostic Plots to Reveal Functional Form for Covariates in Multiplicative Intensity Models
Grambsch, P. M., Therneau, T. M., & Fleming, T. R. (1995) · Biometrics · doi:10.2307/2533277 · Cited by 163
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
Bendifallah, S., Canlorbe, G., Collinet, P., Arsène, E., Huguet, F., Coutant, C., Hudry, D., Graesslin, O., Raimond, É., Touboul, C., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.35 · Cited by 140
Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas
Hoang, L. N., McConechy, M. K., Köbel, M., Han, G., Rouzbahman, M., Davidson, B., Irving, J., Ali, R. H., Leung, S., McAlpine, J. N., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31828c63ed · Cited by 135
Self-citationStelloo, E., Nout, R. A., Naves, L. C. L. M., ter Haar, N. T., Creutzberg, C. L., Smit, V. T. H. B. M., & Bosse, T. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.012 · Cited by 96
Ferguson, S. E., Olshen, A. B., Viale, A. J., Barakat, R. R., & Boyd, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1353 · Cited by 32
Despierre, E., Yesilyurt, B. T., Lambrechts, S., Johnson, N. P., Verheijen, R. H. M., van der Burg, M., Casado, A., Rustin, G. J. S., Berns, E. M. J. J., Leunen, K., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000089 · Cited by 30
Cited by
ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma
Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M. R., Marnitz, S., Ledermann, J., Bosse, T., Chargari, C., Fagotti, A., et al. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-002230 · Cited by 1,989
Crosbie, E. J., Kitson, S. J., McAlpine, J. N., Mukhopadhyay, A., Powell, M. E., & Singh, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00323-3 · Cited by 1,333
Self-citationFIGO staging of endometrial cancer: 2023
Berek, J. S., Matias‐Guiu, X., Creutzberg, C., Fotopoulou, C., Gaffney, D., Kehoe, S., Lindemann, K., Mutch, D., Concin, N., & Endometrial Cancer Staging Subcommittee, F. W. C. C. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14923 · Cited by 1,000
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Talhouk, A., McConechy, M. K., Leung, S., Yang, W., Lum, A., Senz, J., Boyd, N., Pike, J., Anglesio, M., Kwon, J. S., et al. (2017) · Cancer · doi:10.1002/cncr.30496 · Cited by 975
Self-citationLeón-Castillo, A., de Boer, S. M., Powell, M. E., Mileshkin, L. R., Mackay, H. J., Leary, A., Nijman, H. W., Singh, N., Pollock, P. M., Bessette, P., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00549 · Cited by 855
Metadata
- Authors
- Talhouk, A., McConechy, M. K., Leung, S., Li-Chang, H. H., Kwon, J. S., Melnyk, N., Yang, W., Senz, J., Boyd, N., Karnezis, A. N., Huntsman, D. G., Gilks, C. B., & McAlpine, J. N.
- Venue
- British Journal of Cancer
- Published
- 2015-06-30
- Volume
- 113
- Issue
- 2
- Pages
- 299-310
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1565078991
- Cited by
- 971
- References
- 37
- FWCI
- 36.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.